Polydex Pharmaceuticals Limited (OTCMKTS:POLXF – Get Free Report)’s share price crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $1.98 and traded as high as $1.99. Polydex Pharmaceuticals shares last traded at $1.99, with a volume of 2,000 shares.
Polydex Pharmaceuticals Trading Up 0.3 %
The company has a market capitalization of $6.81 million, a price-to-earnings ratio of -8.27 and a beta of 0.46. The stock’s fifty day simple moving average is $1.98 and its 200-day simple moving average is $1.50.
Polydex Pharmaceuticals (OTCMKTS:POLXF – Get Free Report) last posted its quarterly earnings results on Thursday, June 15th. The company reported ($0.04) earnings per share (EPS) for the quarter. The company had revenue of $1.50 million during the quarter. Polydex Pharmaceuticals had a negative net margin of 17.77% and a negative return on equity of 16.50%.
About Polydex Pharmaceuticals
Polydex Pharmaceuticals Ltd. is a development stage company, which engages in manufacturing of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, and the development, manufacturing, and marketing of biotechnology-based products for the human pharmaceutical market.
- Five stocks we like better than Polydex Pharmaceuticals
- How to Choose Top Rated Stocks
- An Electrifying New Upgrade for Tesla Leads the Market Higher
- High Flyers: 3 Natural Gas Stocks for March 2022
- Oil Jumps, 2 Plastic Stocks About To Become Value Plays
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- The Top 5 Analysts Calls in September
Receive News & Ratings for Polydex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polydex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.